Community Acquired Pneumonia: Outpatient and Inpatient Treatment

New Drugs of 2007
Please read through the following information and click continue.

ACPE Universal Program Number: 207-000-08-006-H04-P
Release Date: June 1, 2008
Expiration Date: June 1, 2011

Statement of Need
In 2007, the Food and Drug Administration approved 15 new molecular entities, and numerous new dosage forms. The June continuing education article provides an overview of 13 of the new entities, highlighting important information about their mechanism of action, pharmacokinetic profile, effectiveness, dosing information, and potential side effects and adverse reactions.

Learning Objectives
Upon successful completion of this activity, the pharmacist should be able to:

  1. Identify the new molecular entities approved by the Food and Drug Administration (FDA) in 2007.
  2. Review approved indications, mechanism of action, and pharmacokinetic profile for each agent.
  3. List the available dosage forms and strengths, dosing schedules, and routes of administration for the new agents.
  4. Describe the potential adverse effects, drug interactions, precautions, and contraindications associated with routine use.
  5. Identify medications that have been withdrawn from the market in 2007.
    6.

Target Audience
The target audience for this program is pharmacists.

Instructions for Participation
To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:

  • Review the content of the activity.
  • Successfully complete the post-test (70% or higher).
  • You will have two (2) opportunities to successfully complete the activity.

Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.

Fee
There is no fee for this activity.

Accreditation
Pharmacists
ACPE logoNCPA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program will provide 2.0 contact hours (.20 CEUs) of continuing pharmacy education credit under the number 207-000-08-006-H04-P.

 

Faculty
Amy P. Witte, PharmD, and Jodie V. Mahlhotra, PharmD, are assistant professors of pharmacy practice at the University of the Incarnate Word, Feik School of Pharmacy, San Antonio. Trevor McKibbin, PharmD, MSc, BCPS, is an assistant professor of clinical pharmacy at the University of Tennessee College of Pharmacy, Memphis, Tennessee.

Disclosure Declaration
It is the policy of the National Community Pharmacists Association (NCPA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.

Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.

Software Requirement

PC
Windows 2000
Internet Explorer 5.5 or Firefox
*Adobe Acrobat Reader

MAC
Mac OS 10.2.8
Safari
*Adobe Acrobat Reader

*REQUIRED TO VIEW PRINTABLE VERSION OF CE LESSON

 

 

 




Continue